scholarly journals Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double-blind placebo-controlled trial

2016 ◽  
Vol 18 (4) ◽  
pp. 392-400 ◽  
Author(s):  
N. G. Forouhi ◽  
R. K. Menon ◽  
S. J. Sharp ◽  
N. Mannan ◽  
P. M. Timms ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
At Risk ◽  
Glycaemic Control ◽  
Cardiometabolic Risk ◽  
Controlled Trial ◽  
Vitamin D2 ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Effects of semaglutide on beta cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trial

Diabetologia ◽  
2017 ◽  
Vol 60 (8) ◽  
pp. 1390-1399 ◽  
Author(s):  
Christoph Kapitza ◽  
Kirsten Dahl ◽  
Jacob B. Jacobsen ◽  
Mads B. Axelsen ◽  
Anne Flint
Keyword(s):  
Type 2 Diabetes ◽  
Glycaemic Control ◽  
Beta Cell ◽  
Beta Cell Function ◽  
Cell Function ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo

Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial

The Lancet ◽  
2010 ◽  
Vol 375 (9733) ◽  
pp. 2223-2233 ◽  
Author(s):  
Clifford J Bailey ◽  
Jorge L Gross ◽  
Anne Pieters ◽  
Arnaud Bastien ◽  
James F List
Keyword(s):  
Type 2 Diabetes ◽  
Glycaemic Control ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document